When your beloved feline is diagnosed with Feline Infectious Peritonitis (FIP), finding effective and affordable treatment options becomes an urgent priority. Once deemed a fatal disease, FIP now has two promising therapies, GS-441524 and molnupiravir, that offer hope to pet parents and veterinarians alike. At PetScript, we're leading the charge in making these life-saving medications accessible without breaking the bank, serving as the only veterinary-exclusive pharmacy to offer both options. This flexibility empowers veterinarians to tailor treatments that best suit each unique case, ensuring that every cat has the best chance at recovery. Join us as we explore how PetScript is revolutionizing FIP treatment with an emphasis on affordability and accessibility.
If you don't have a PetScript Account, Click here to create one today!
Feline Infectious Peritonitis (FIP) once left cat owners with few options, but today, the landscape is changing. PetScript is revolutionizing access to FIP Treatment by offering both GS-441524 and molnupiravir. This dual approach gives veterinarians and pet parents more flexibility in tailoring care.
Visit PetScript Pharmacies FIP page by clicking here -
Every patient is unique, requiring individualized care. GS-441524 and molnupiravir each have their own strengths. GS-441524 is favored for its proven track record, while molnupiravir is gaining attention for its ease of administration.
Offering both medications ensures that veterinarians can make evidence-based decisions without delay. This flexibility is crucial, as the best treatment option often depends on a cat’s health, age, and clinical signs.
Moreover, combining both options allows continuity of care. If one treatment doesn't yield the desired results, the other can be an alternative solution. This adaptability can be the difference in improving a pet’s quality of life.
PetScript empowers veterinarians to customize FIP Treatment plans. This approach considers the specific needs of each feline patient, from dosage to administration method.
Assess the cat’s overall health and clinical signs.
Determine the preferred treatment—GS-441524 or molnupiravir—based on veterinarian recommendations.
Administer treatment and monitor the cat’s progress.
This level of customization ensures that the treatment is as effective as possible. Veterinarians have the freedom to switch therapies if the initial choice isn't optimal, ensuring that every cat has the best chance of recovery.
Understanding the available FIP Treatment options is crucial for making informed decisions. Both GS-441524 and molnupiravir offer promising results, yet each comes with unique benefits and considerations.
GS-441524 has been widely used in the FIP Treatment market with successful outcomes. As an active metabolite of remdesivir, it has been pivotal in the fight against FIP.
Administered subcutaneously, typically on a daily schedule.
Has shown over 80% success rates in remission.
Supported by research from U.C. Davis.
This medication is ideal for cats that can handle injections and those requiring a more traditional therapeutic approach. Scientific backing and clinical success make it a reliable choice for many veterinarians.
Molnupiravir is a newer agent showing strong potential in FIP Treatment. Its oral administration is convenient for many pet owners.
Administered orally, twice daily.
Preliminary research indicates similar remission rates to GS-441524.
Offers a less invasive option for cats averse to injections.
A 2024 study highlighted its effectiveness and safety, particularly for cats with effusive FIP. The convenience of pills makes it an appealing choice for both pet parents and veterinarians looking to ease the treatment process.
Click here to order Molnupiravir Oral Suspension
Accessibility and affordability are at the forefront of PetScript’s mission. We understand the financial burden that FIP Treatment can place on families and strive to make these medications available to all.
PetScript is dedicated to offering fair pricing without compromising on quality.
We provide competitive pricing that rivals other pharmacies.
Our price matching ensures you’re always getting the best deal.
By maintaining low prices, we make life-saving medications more accessible, easing the financial strain on pet owners. This commitment to affordability reflects our dedication to serving both pets and their families.
With over two decades of experience, PetScript stands out as a leader in veterinary-exclusive compounding.
Proven expertise in quality and consistency.
Prompt delivery and compassionate customer support.
A track record of excellence in veterinary care.
Our long-standing presence in the industry reassures pet parents that they’re receiving reliable, top-notch service. This legacy of excellence underscores our commitment to advancing FIP Treatment and improving cat health.
PETSCRIPT is your go-to destination for all compounded medications PetScript is known for excellent customer service, prompt response times and the highest quality compounded medications at the best price. Our combined experience spanning 45 years also takes our credibility a notch higher.
© 2025, PetScript Pharmacy
This content is intended for counseling purposes only. This content is informational/educational and is not intended to treat or diagnose any disease or patient. No claims are made as to the safety or efficacy of mentioned preparations. The compounded medications featured in this content have been prescribed and/or administered by prescribers who work with ProLab Pharmacy. You are encouraged to speak with your prescriber as to the appropriate use of any medication. ProLab Pharmacy’s compounded veterinary preparations are not intended for use in food and food-producing animals. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them..